Downregulation of TAP1 in Tumor-Free Tongue Contralateral to Squamous Cell Carcinoma of the Oral Tongue, an Indicator of Better Survival

. 2020 Aug 27 ; 21 (17) : . [epub] 20200827

Jazyk angličtina Země Švýcarsko Médium electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid32867395

Grantová podpora
180542 Cancerfonden
2019 Umea University
2019 Lion's cancer research foundation
2019 Region Västerbotten
MMCI, 00209805 Ministry of health Czech Republic

Oral cancers are surrounded by epithelium that histologically might seem normal, but genetically has aberrations. In patients with squamous cell carcinoma of the oral tongue (SCCOT), it is therefore important to study not only the tumor but also the clinically tumor-free contralateral tongue tissue that remains in the patient after treatment to map changes of prognostic and/or diagnostic value. The transporter associated with antigen processing (TAP) dimer is a key factor in the process of activating cytotoxic T cells. By downregulating the expression of TAP, tumor cells can escape cytotoxic T cell recognition. Biopsies from tumor and clinically tumor-free contralateral tongue tissue in 21 patients with SCCOT were analyzed together with tongue biopsies from 14 healthy individuals, which served as the control group. Dividing patients into TAP1-high and TAP1-low groups according to the median TAP1 level in tumor-free samples showed that patients with lower TAP1 mRNA levels in tumor-free samples had better overall (p = 0.003) and disease-free survival (p = 0.002). The results showing that TAP1 levels in tumor-free tongue tissue contralateral to the SCCOT correlate with survival is an important contribution to early diagnosis and follow up of SCCOT.

Zobrazit více v PubMed

Sgaramella N., Gu X., Boldrup L., Coates P.J., Fåhraeus R., Califano L., Tartaro G., Colella G., Spaak L.N., Strom A., et al. Searching for New Targets and Treatments in the Battle Against Squamous Cell Carcinoma of the Head and Neck, with Specific Focus on Tumours of the Tongue. Curr. Top. Med. Chem. 2018;18:214–218. doi: 10.2174/1568026618666180116121624. PubMed DOI

Sano D., Myers J.N. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev. 2007;26:645–662. doi: 10.1007/s10555-007-9082-y. PubMed DOI

Slaughter D.P., Southwick H.W., Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6:963–968. doi: 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q. PubMed DOI

Braakhuis B.J., Tabor M.P., Kummer J.A., Leemans C.R., Brakenhoff R.H. A genetic explanation of Slaughter’s concept of field cancerization: Evidence and clinical implications. Cancer Res. 2003;63:1727–1730. PubMed

Lochhead P., Chan A.T., Nishihara R., Fuchs C.S., Beck A.H., Giovannucci E., Ogino S. Etiologic field effect: Reappraisal of the field effect concept in cancer predisposition and progression. Mod. Pathol. 2015;28:14–29. doi: 10.1038/modpathol.2014.81. PubMed DOI PMC

Gu X., Boldrup L., Coates P.J., Fahraeus R., Wang L., Wilms T., Norberg-Spaak L., Sgaramella N., Nylander K. High immune cytolytic activity in tumor-free tongue tissue confers better prognosis in patients with squamous cell carcinoma of the oral tongue. J. Pathol. Clin. Res. 2019;5:240–247. doi: 10.1002/cjp2.138. PubMed DOI PMC

Rosenberg J., Huang J. CD8+ T cells and NK cells: Parallel and complementary soldiers of immunotherapy. Curr. Opin. Chem. Eng. 2018;19:9–20. doi: 10.1016/j.coche.2017.11.006. PubMed DOI PMC

Abele R., Tampe R. The ABCs of Immunology: Structure and Function of TAP, the Transporter Associated with Antigen Processing. Physiology. 2004;19:216–224. doi: 10.1152/physiol.00002.2004. PubMed DOI

Ritz U., Seliger B. The Transporter Associated With Antigen Processing (TAP): Structural Integrity, Expression, Function, and Its Clinical Relevance. Mol. Med. 2001;7:149–158. doi: 10.1007/BF03401948. PubMed DOI PMC

Eggensperger S., Tampe R. The transporter associated with antigen processing: A key player in adaptive immunity. Biol. Chem. 2015;396:1059–1072. doi: 10.1515/hsz-2014-0320. PubMed DOI

Lankat-Buttgereit B., Tampe R. The Transporter Associated With Antigen Processing: Function and Implications in Human Diseases. Physiol. Rev. 2002;82:187–204. doi: 10.1152/physrev.00025.2001. PubMed DOI

Bandoh N., Ogino T., Katayama A., Takahara M., Katada A., Hayashi T., Harabuchi Y. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis. Oncol. Rep. 2010;23:933–939. doi: 10.3892/or_00000717. PubMed DOI

Boldrup L., Gu X., Coates P.J., Norberg-Spaak L., Fåhraeus R., Laurell G., Wilms T., Nylander K. Gene expression changes in tumor free tongue tissue adjacent to tongue squamous cell carcinoma. Oncotarget. 2017;8:19389–19402. doi: 10.18632/oncotarget.14288. PubMed DOI PMC

Meissner M., Reichert T.E., Kunkel M., Gooding W., Whiteside T.L., Ferrone S., Seliger B. Defects in the Human Leukocyte Antigen Class I Antigen Processing Machinery in Head and Neck Squamous Cell Carcinoma: Association with Clinical Outcome. Clin. Cancer Res. 2005;11:2552–2560. doi: 10.1158/1078-0432.CCR-04-2146. PubMed DOI

Han W., Pan H., Jiang L., Wei K., Zou D., Zhang Z. A novel approach to rescue immune escape in oral squamous cell carcinoma: Combined use of interferon-γ and LY294002. Oncol. Rep. 2011;25:181–187. PubMed

Wei H., Hongya P., Linlin J., Mujiang A., Kuijie W., Duohong Z., Qingang H., Zhiyuan Z. IFN-γ enhances the anti-tumour immune response of dendritic cells against oral squamous cell carcinoma. Arch. Oral Biol. 2011;56:891–898. doi: 10.1016/j.archoralbio.2011.02.008. PubMed DOI

Tanaka K., Tsuchikawa T., Miyamoto M., Maki T., Ichinokawa M., Kubota K.C., Shichinohe T., Hirano S., Ferrone S., Dosaka-Akita H., et al. Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients. Int. J. Oncol. 2012;40:965–974. doi: 10.3892/ijo.2011.1274. PubMed DOI PMC

Henle A.M., Nassar A., Puglisi-Knutson D., Youssef B., Knutson K.L. Downregulation of TAP1 and TAP2 in early stage breast cancer. PLoS ONE. 2017;12:e0187323. doi: 10.1371/journal.pone.0187323. PubMed DOI PMC

Ling A., Löfgren-Burström A., Larsson P., Li X., Wikberg M.L., Öberg Å., Stenling R., Edin S., Palmqvist R. TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer. OncoImmunology. 2017;6:e1356143. doi: 10.1080/2162402X.2017.1356143. PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...